Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Cancer. 2017 Jan 13;123(9):1590–1596. doi: 10.1002/cncr.30526

Table 1.

Demographics

Full Sample (n=20,916)
Whites (n=17,574)
Blacks (n=3,342)
Continuous Variables M SD M SD M SD t1
Age 77.1 7.0 77.3 7.0 75.9 7.0 10.94***
MHI (in thousands) 49.7 24.1 52.4 24.2 35.5 17.3 47.55***
Categorical Variables % N % N % N x2

Sex
 Male 52 10,988 54 9,432 47 1,556 56.95***
 Female 48 9,928 46 8,142 53 1,786
Medicaid Beneficiary
 Yes 15 3,089 11 1,966 34 1,123 1120.89***
 No 85 17,287 89 15,608 66 2,219
Urban/Rural Status
 Metro 83 17,378 82 14,484 87 2,894 52.74***
 Urban 15 3,087 15 2,667 13 420
 Rural 2 444 2 418 1 26
Performance Status
 Normal 80 16,643 81 14,189 73 2,454 92.29***
 Poor 20 4,273 19 2,454 27 888
CCI
 0 51 10,619 53 9,261 41 1,358 223.98***
 1 23 4,806 23 4,013 24 793
 2 12 2,595 12 2,073 16 522
 3+ 14 2,896 13 2,227 20 669
SCT Utilization2
 Yes 7 782 8 700 4 82 34.37***
 No 93 10,487 92 8,506 96 1,981
BTZ Utilization3
 Yes 35 5,672 36 4,882 30 790 39.10***
 No 65 10,365 64 8,525 70 1,840

Note: BTZ= Bortezomib; CCI= Charlson Comorbidity Index; MHI= Median Household Income; SCT = Stem Cell Transplant;

*

= p < 0.01;

**

= p < 0.001;

***

= p < 0.0001.

1

T and P values for comparison between whites and blacks

2

Limited to only those ≤77 years old at MM diagnosis (n= 11,269)

3

Limited to only those diagnosed 2003–2011 (n= 16,037)